| Company/Partner | Drug Name | Launch Date |
| Amgen | Amjevita* | January 2023 |
| Samsung Bioepis/Merck | SB5 | June 2023 |
| Mylan/Fujifilm Kyowa Kirin Biologics | Hulio | August 2023 |
| Fresenius Kabi | MSB11022 | September 2023 |
| Sandoz | Hyrimoz* | September 2023 |
| Pfizer | PF-06410293 | November 2023 |
| Momenta | M923 | December 2023 |
| Coherus | CHS-1720 | December 2023 |
| *Received FDA Approval. |
Update: Who Has Signed Abbvie Licensing Agreements for Adalimumab Biosimilars?
Published